INHIBINOL AI
DEAD

Serial Number

90627244

Owner

Skymount Technologies LLC

Attorney

Kimberly N. Fisher

Filing Date

Apr 6, 2021

Add to watchlist:

No watchlists yet
View on USPTO

INHIBINOL AI Trademark

Serial Number: 90627244

INHIBINOL AI is a trademark filed by Skymount Technologies LLC on April 6, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Skymount Technologies LLC (5 trademarks)

New Orleans, LA 70130

Entity Type: 16

INHIBINOL AI C- CORP (2 trademarks)

3900 N CAUSEWAY BLVD., SUITE 1200
METAIRIE, LA 70002

Entity Type: 03

Trademark Details

Filing Date

April 6, 2021

Registration Date

Not Registered

Published for Opposition

June 27, 2023

Goods & Services

Nutraceuticals for use as a dietary supplement; pharmaceutical preparations for the treatment of dietary diseases, cardiovascular diseases, disorders and infections, respiratory diseases, disorders and infections, and eye infections; Anti-inflammatory preparations; Anti-inflammatories; Nutraceuticals for the treatment of respiratory and dietary diseases; Antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; botanicals extracts for the treatment of colds and flu; cardiovascular nutraceutical preparations; herbal supplements for the treatment of the respiratory system; nutraceuticals for regulating the immune system; nutraceuticals for the treatment of infectious diseases, namely, respiratory infections, eye infections; nutraceuticals for the treatment of respiratory diseases, disorders and infections; nutraceuticals for the treatment of the respiratory system; nutraceuticals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; nutraceuticals for treating respiratory diseases; nutraceuticals for the treatment of coronavirus diseases and COVID-19; vitamin and mineral preparations for medical use

Vitamins for use in the manufacture of nutraceuticals

development of pharmaceutical preparations, nutraceuticals, and medicines; pharmaceutical and nutraceutical product development services; research and development of new products for others; drug and nutraceutical product discovery services in the nature of product research; AI-driven development of pharmaceutical preparations, nutraceuticals, and medicines; research and development of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical and nutraceutical product evaluation

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 23, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 23, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 23, 2024 EXRA
SOU EXTENSION 1 GRANTED
Feb 22, 2024 EX1G
SOU EXTENSION 1 FILED
Feb 22, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 22, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 22, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 27, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 27, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 7, 2023 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 23, 2023 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 13, 2023 CNSA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 26, 2023 ASGN
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 15, 2023 ERFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 4, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 4, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 4, 2022 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 15, 2022 GNFN
FINAL REFUSAL E-MAILED
Sep 15, 2022 GNFR
FINAL REFUSAL WRITTEN
Sep 15, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2022 CRFA
ASSIGNED TO LIE
Jun 16, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 8, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 8, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 8, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 8, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 29, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2021 NWOS
NEW APPLICATION ENTERED
Apr 9, 2021 NWAP